N/A
N=12
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) During Pregnancy
Cardiovascular Diseases · Pregnancy Related · Sedentary Behavior
Bottom Line
View on ClinicalTrials.gov: NCT05822531 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Feasibility of Integrating a Cardiovascular Health Module to the Existing Nurse-Family Partnership (NFP) Home Visiting Program as Measured by Qualitative Feedback From Home Visitors. — 7 Participants reporting success
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Maternal CVH Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Penn State University
- Primary completion
- Jun 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Integrating a Cardiovascular Health Module to the Existing Nurse-Family Partnership (NFP) Home Visiting Program as Measured by Qualitative Feedback From Home Visitors. |
7 | — |
Summary
This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.
Eligibility Criteria
Inclusion Criteria
- Nulliparous pregnant woman
- Age ≥ 18 years old
- Enrolled in and receiving the Nurse-Family Partnership program through the Geisinger Clinic or UPMC Home Health Care of Central PA
- English speaking
- Women with a singleton viable pregnancy confirmed by NFP home visitors
- Access to reliable internet service required for data collection
- A minimum of 5 women with use of nicotine containing products (cigarette, cigar, hookah, chewing tobacco, e-cigarette, patch) within the past 3 months
Exclusion Criteria
- Unable or unwilling to comply with the study visits and procedures
- Participation in a concurrent interventional study
- Diagnosis of cancer
- A personal history of complex congenital heart disease
- A fetus in the current pregnancy with known chromosomal abnormalities or birth defects inconsistent with survival to 2 years will be excluded
Data sourced from ClinicalTrials.gov (NCT05822531). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.